DexCom
DXCM
NZ$138.64
Share price
-2.45%
Change (1 day)
-25.55%
Change (1 year)
Categories
DexCom (DXCM) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$7.45 Billion
According to DexCom's latest financial reports the company's total liabilities are NZ$7.45 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
DexCom - Total liabilities on balance sheet (from 2005 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$7.76 B | 17.1% |
| 2023-12-31 | NZ$6.63 B | 29.22% |
| 2022-12-31 | NZ$5.13 B | 21.3% |
| 2021-12-31 | NZ$4.23 B | 23.95% |
| 2020-12-31 | NZ$3.41 B | 52.07% |
| 2019-12-31 | NZ$2.24 B | 20.25% |
| 2018-12-31 | NZ$1.86 B | 173.64% |
| 2017-12-31 | NZ$0.68 B | 297.27% |
| 2016-12-31 | NZ$0.17 B | 66.07% |
| 2015-12-31 | NZ$0.10 B | 82.55% |
| 2014-12-31 | NZ$56.66 M | 21.27% |
| 2013-12-31 | NZ$46.72 M | 32.56% |
| 2012-12-31 | NZ$35.25 M | 71.96% |
| 2011-12-31 | NZ$20.5 M | -2.19% |
| 2010-12-31 | NZ$20.96 M | -76.72% |
| 2009-12-31 | NZ$90.03 M | -17.53% |
| 2008-12-31 | NZ$0.10 B | 19.21% |
| 2007-12-31 | NZ$91.57 M | 735.12% |
| 2006-12-31 | NZ$10.96 M | 2.47% |
| 2005-12-31 | NZ$10.7 M | -90.29% |
| 2004-12-31 | NZ$0.11 B | 34.29% |
| 2003-12-31 | NZ$82.09 M | |
| 2001-12-31 | NZ$42.31 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | NZ$4.70 B | -36.89% | 🇺🇸 USA |
 Becton Dickinson BDX | NZ$48.60 B | 551.62% | 🇺🇸 USA |
 West Pharmaceutical WST | NZ$1.55 B | -79.15% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | NZ$1.27 B | -82.90% | 🇺🇸 USA |
 Medtronic MDT | NZ$72.21 B | 868.18% | 🇮🇪 Ireland |
 Abbott Laboratories ABT | NZ$53.85 B | 622.04% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$192.17 B | 2,476.58% | 🇺🇸 USA |
 QuidelOrtho QDEL | NZ$5.76 B | -22.76% | 🇺🇸 USA |